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Summary
Creutzfeldt-Jakob disease (CJD) is a neurodegenerative disorder belonging to the group of transmissible 
spongiform encephalopathies. The transition of physiological, soluble, neuroprotective prion protein PrPc into 
its insoluble, misfolded isoform PrPSc remains its central pathogenic event. The progressive accumulation of 
isoform PrPSc within the brain tissue results in spongiform degeneration and a plethora of clinical symptoms. 
Typically, CJD manifests as progressive dementia with myoclonus, visual or cerebellar dysfunction, pyramidal/
extrapyramidal signs or akinetic mutism. However, a growing number of studies indicate that CJD may present 
with prodromal psychiatric manifestations including anhedonia, anxiety, irritability, depression, insomnia, psy-
chosis and catatonic behavior. We present a case of CJD with a history of prodromal psychiatric symptoms 
and catatonic behavior diagnosed by brain biopsy.
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INTRODUCTION
Creutzfeldt-Jakob	disease	(CJD)	is	a	neuro-
degenerative disorder belonging to the group 
of transmissible spongiform encephalopathies. 
The transition of physiological, soluble, neuro-
protective prion protein PrPc into its insoluble, 
misfolded	isoform	PrPSc	remains	the	central	
pathogenic	event	in	this	disorder	[1].	PrPSc	cre-
ates toxic deposits resilient to cellular clearance 
mechanisms [2]. Their progressive accumulation 
within the brain tissue results in spongiform de-
generation and a plethora of clinical symptoms. 
Typically,	CJD	manifests	as	progressive	demen-
tia with myoclonus, visual or cerebellar dysfunc-
tion, pyramidal/extrapyramidal signs or akinetic 
mutism. However, a growing number of studies 
indicate	that	CJD	may	present	with	prodromal	
psychiatric manifestations including anhedo-
nia, anxiety, irritability, depression, insomnia, 
psychosis and behavioral changes [3]. Brown et 
al. [4] showed that behavioral changes occurred 
in 30% of patients at the disease onset and in 
57% at the later stages. In another study, 5 out 
of	8	CJD	patients	showed	psychiatric	manifesta-
tion including mood, thought and behavior dis-
ruption; 4 out of 8 of these patients were diag-
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nosed with different psychiatric disorders [5]. 
Mood disorder symptoms, paranoid ideation 
and hallucinations were present in 7 out of 11 
CJD	cases	described	in	the	study	by	Satishchan-
dra et al. [6]. A retrospective study indicated that 
18–39%	of	patients	with	sporadic	CJD	present-
ed with psychiatric symptoms such as depres-
sive disorder, emotional lability or personality 
changes	[7].	CJD	cases	from	Brazil	presented	by	
Sobreira	et	al.	[8]	showed	heterogeneous	psychi-
atric manifestations including sudden psycho-
motor agitation, aggression, disinhibition and 
cognitive dysfunctions. Moreover, it was report-
ed that early stages of the disease may manifest 
as dissociative disorder with histrionic behav-
ior	and	dissimulation	[9].	Siwek	et	al.	[10]	pre-
sented	a	case	of	a	34-year-old	female	with	CJD,	
primarily diagnosed with conversion disorder, 
who manifested with blurred vision, diplopia 
and gait impairment. All of these reported cases 
indicate	that	CJD	may	manifest	with	a	plethora	
of uncharacteristic, atypical psychiatric symp-
toms and it is likely that psychiatrists may be 
the	first-line	doctors	dealing	with	a	CJD	patient	
at the early stages of the disease [11].
Catatonia is a neuropsychiatric syndrome 
characterized by mutism, stupor, negativism 
and hypo/hyperkinesis. While it is mostly as-
sociated with schizophrenia, catatonia is often 
caused by affective disorders and neurologi-
cal	illnesses	[12].	We	present	a	case	of	CJD	diag-
nosed by brain biopsy in a patient with a histo-
ry of prodromal psychiatric symptoms and cat-
atonic behavior.
CASE
A 49-year-old woman was admitted to a psy-
chiatric hospital for the first time 9 months be-
fore the proper diagnosis was established, due 
to her bizarre behavior, deterioration of so-
cial interactions, reduced food intake, halluci-
nations, psychomotor retardation with period-
ic episodes of agitation, passive negativism and 
sleep disorders. All symptoms, lasting for a peri-
od of 4 weeks, indicated an acute psychotic dis-
order and the patient was discharged on olan-
zapine 5mg daily and biperiden 2mg daily. Af-
ter the discharge, the patient’s family observed 
a deterioration in her health; she ceased to be 
independent and required assistance with ba-
sic activities. There was also a significant deteri-
oration	in	her	vision.	Due	to	lowered	mood	and	
psychomotor retardation, the patient was ad-
mitted to the psychiatric hospital for the second 
time. Her symptoms remained stable except for 
increasing muscle rigidity. An electroencepha-
logram (EEG) test showed pathological tracing 
with diffused and generalized paroxysmal theta 
activity.	She	was	discharged	with	the	diagnosis	
of drug-induced Parkinsonism and treated with 
biperiden 2mg three times a day without con-
comitant antipsychotic medication. A month lat-
er, the patient was again admitted to the psychi-
atric hospital because of aggressive and agitated 
behavior. A hostile attitude towards the hospi-
tal staff was also marked. The patient’s condition 
gradually deteriorated further, with mutism, in-
creased hypertonia and negativism. The clinical 
picture tended towards a suspicion of the cata-
tonic syndrome. Olanzapine 10mg daily was ad-
ministered. However, after several days the pa-
tient’s body temperature went up to 39ºC and 
olanzapine was discontinued. As infection was 
suspected, she was started on intravenous ceftri-
axone. However, subsequent internal medicine 
consultation with blood and urine culture and 
cerebrospinal	fluid	(CSF)	examination	as	well	as	
head computed tomography (CT) excluded the 
suspected source of infection (including neuro-
infection), leading to a suspicion of neuroleptic 
malignant syndrome.
Finally, due to unclear clinical presentation, 
the	patient	was	admitted	to	the	Clinical	Depart-
ment	of	Adult	Psychiatry	at	the	University	Hos-
pital in Kraków in a state of consciousness re-
quiring differentiation between stupor and veg-
etative state. The physical examination revealed 
eyes opening spontaneously and no verbal con-
tact, but the patient responded with a grimace 
to	painful	stimulation.	No	spontaneous	move-
ments, hypertonia and muscle atrophy of the 
upper and lower limbs were present. Because 
of dysphagia, the patient was supported with 
a feeding tube.
A consecutive neurological examination iden-
tified spastic quadriplegia and jaw muscles spasm. 
The palmomental reflex was present on the left 
side. The clinical picture of progressive encepha-
lopathy of unknown etiology suggested further di-
agnostic	evaluation	towards	CJD.	Head	magnetic	
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resonance imaging (MRI) revealed diffuse linear 
cortical enhancement at diffusion-weighted imag-
ing sequence. The neuroimaging result prompted 
the	team	to	consider	a	CJD	diagnosis	despite	lack	
of typical changes in the basal ganglia.
The patient, conscious with no verbal contact, 
was	then	admitted	to	the	Neurology	Department	
at	the	University	Hospital	in	Kraków.	Neuro-
logical examination showed spastic quadriple-
gia (more severe on the right side) with hyper-
reflexia and four limbs’ contractures. The EEG 
showed generalized slow activity without rhyth-
mic	slow	waves	typical	for	CJD	and	CSF	analysis	
did not reveal 14–3–3 protein elevation. Because 
of	the	lack	of	typical	CJD	findings	from	the	EEG	
and	CSF	examination	and	a	concomitant	clinical	
and MRI picture suggesting diffuse encephalop-
athy, brain biopsy was performed after obtain-
ing the approval from a family court.
Applying the method of open brain biopsy, 
the sample of approximately 1.5cm in diameter 
containing both the cortex and subcortical white 
matter was obtained from the left temporal lobe. 
The tissue was treated accordingly to the uni-
versally accepted methods for handling tissue 
suspected of being “infected” with a pathogen-
ic prion strain, including 1h immersion in formic 
acid. Histopathological investigations including 
immunohistochemistry were made on sections 
of samples embedded in paraffin blocks. Hema-
toxylin	and	eosin	(H&E)	staining	showed	vacu-
olization in the neuropil and neuronal loss indi-
cating spongiform degeneration (Fig. 1). Immu-
nohistochemical staining for PrP demonstrated 
immunopositive deposits around spongiform 
changes resistant to autoclaving and proteinase 
K digestion (Fig. 2). These results confirmed the 
diagnosis	of	CJD	in	our	patient.
Fig 1. Brain biopsy, left temporal lobe, H&E staining. Vacuolization in the neuropil and neuronal loss indicate spongiform 
degeneration.
Fig 2. Brain biopsy, left temporal lobe, immunohistochemical staining for PrP. Immunopositive deposits around the spongiform 
change may be observed (arrowhead).
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DISCUSSION
Reports	 indicate	that	CJD,	as	well	as	other	
prion diseases like fatal familial insomnia, may 
manifest as catatonia [13]. Table 1 presents pub-
lished	cases	of	CJD	patients	presenting	with	cat-
atonic behavior. Our case report and collected 
data point out several features facilitating dif-
ferential diagnosis between catatonic behavior 
observed in mental disorders and that observed 
in	CJD.	Those	features	include:	short	duration	of	
illness, rapid deterioration, and no improvement 
in psychiatric symptoms despite pharmacologi-
cal treatment. Patients may often be wrongly di-
agnosed with neuroleptic malignant syndrome 
[14].
Tab 1. Published cases of CJD patients presenting with catatonic behavior 
Age Gender Type of 
CJD
Duration 
of illness 
(months)
Psychiatric symptoms 
before catatonic 
behavior
Neuroimaging EEG CSF
51 Female sCJD 4 Reduced attention 
and concentration, 
insomnia, decreased 
psychomotor 
activity, deteriorating 
memory function, 
anhedonia, anxiety 
irritability, propensity 
to cry, diagnosis of 
depression for 20 
years
MRI: mild generalized 
cerebral and 
cerebellar atrophy
DWI: areas of cortical 
diffusion restriction 
and slow wave 
complexes
Bilateral periodic 
lateralized 
epileptiform 
discharges
14–3–3 and 
tau protein 
elevation
35 Male nvCJD 3 Fatigue, decreased 
interaction, mood 
swings
MRI: high signal 
intensity on T2WI 
and fluid attenuated 
inversion recovery 
(FLAIR) in caudate 
nucleus, thalamus 
bilaterally (hockey 
stick sign), posterior 
cingulate and parietal 
lobe
DWI: bilateral 
symmetric 
hyperintense signals 
in the caudate, frontal, 
parietal and occipital 
regions
Diffuse slowing of 
background activity to 
delta range
Negative
52 Female CJD 4 Depressive 
symptoms, confusion, 
disorientation, 
insomnia, loss of 
appetite, periodic 
agitation, anxiety, 
delusions
Unremarkable Generalized 
background slowing 
with a few irregular 
sharp waves
Negative
52	 A.A.	Chrobak,	A.	Dudek,	M.	Wnuk,	Z.	Łysiak,	M.	Siwek,	D.	Adamek,	A.	Świerkosz,	D.	Dudek
Archives of Psychiatry and Psychotherapy, 2016; 2: 48–53
59 Female sCJD 5 Impulsive and 
socially inappropriate 
behavior, 
somnolence, 
withdrawal, memory 
deficits, vocal tics 
with grunting and 
barking, Tourette 
syndrome-like 
sounds, involuntary 
movements
Unremarkable Initial EEG: 
nonspecific 
background slowing, 
after 5 months – 
periodic sharp wave 
complexes typical of 
sCJD
14–3–3 and 
tau protein 
elevation
60 Male CJD 4 Anxiety, visual 
hallucinations, 
depression
DWI: cortical ribbon 
sign and hyperintense 
caudate nucleus
Periodic triphasic 
sharp waves
Negative 
for viral 
markers, 
14–3–3 not 
evaluated
80 Female sCJD 29 Anxiety, anhedonia, 
fatigue, depressed 
mood, apathy, 
psychomotor 
retardation
MRI: bilateral 
temporal-occipital 
cortex predominantly 
left hemispheric 
alterations with 
integrity of basal 
ganglia
DWI: bilateral parieto-
occipital cortical 
hyperintensities that 
affected several gyri
Slowness and diffuse 
period sharp wave 
complexes (PSWC) 
predominantly in left 
hemisphere
Elevated 
14–3–3
CJD, Creutzfeld-Jakob disease; nvCJD, new variant CJD; sCJD, sporadic CJD; vCJD, variant CJD; CSF, cerebrospinal fluid; DWI; diffusion-
-weighted magnetic resonance imaging; EEG, electroencephalogram; MRI, magnetic resonance imaging.
Electroconvulsive therapy (ECT), which re-
mains the predominant method of treatment in 
catatonia,	may	not	only	be	ineffective	in	CJD,	but	
in some cases may also be associated with symp-
toms’ progression. Grande et al. [15] reported 
a	case	of	CJD	patient	who,	after	eight	bilater-
al ECT sessions in 25 days, became disoriented, 
inattentive and perseverative, with hypophon-
ic, monotonous speech with a paucity of con-
tent and difficulties in naming and understand-
ing complex orders. The patient also developed 
rigidity, postural tremor, bradykinesia, gait dis-
turbances and became wheelchair bound [15]. In 
such cases of ECT-resistant catatonic behavior, 
EEG,	MRI	and	CSF	examinations	should	be	con-
ducted. The EEG pattern differs depending on 
the stage of the disease. In the early stages, dif-
fuse slowing and frontal rhythmic delta activi-
ty	(FIRDA)	may	be	present,	whereas	the	middle	
and	late	stages	of	sporadic	CJD	(sCJD)	present	
with disease-typical periodic sharp wave com-
plexes	(PSWC)	[16].	Control	EEG	performed	in	
the presented case revealed a pattern character-
istic	for	sCJD.	Thus,	there	was	no	need	for	fur-
ther	diagnostics	for	variant	CJD	(vCJD)	(e.g.	ton-
sil biopsy).
In	CSF	tests,	elevated	14–3–3	protein	is	detect-
ed	in	about	90%	cases	of	sCJD,	but	in	only	50%	
cases	of	vCJD	[17].	However,	histological	exam-
ination is the only method of final diagnosis. 
Brain biopsy sampling may be helpful in the di-
agnostic approach to rare cases of atypical man-
ifestation	of	this	disease,	when	CSF	parameters,	
EEG and MRI results are inconsistent and neu-
ropsychological examination is not possible [18].
The	presented	case	indicates	that	sCJD	should	
be considered in the wide differential diagnosis 
of catatonic behavior, especially when there is 
a short duration of psychiatric symptoms and 
their resistance to treatment, as well as rapid de-
terioration of patient’s health.
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